| Product NDC: | 47781-267 |
| Proprietary Name: | Cefaclor |
| Non Proprietary Name: | Cefaclor |
| Active Ingredient(s): | 500 mg/1 & nbsp; Cefaclor |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 47781-267 |
| Labeler Name: | Alvogen, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065146 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100118 |
| Package NDC: | 47781-267-03 |
| Package Description: | 30 CAPSULE in 1 BOTTLE, PLASTIC (47781-267-03) |
| NDC Code | 47781-267-03 |
| Proprietary Name | Cefaclor |
| Package Description | 30 CAPSULE in 1 BOTTLE, PLASTIC (47781-267-03) |
| Product NDC | 47781-267 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cefaclor |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100118 |
| Marketing Category Name | ANDA |
| Labeler Name | Alvogen, Inc. |
| Substance Name | CEFACLOR |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |